Literature DB >> 15317701

Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer.

M R Stevenson1, P M Hart, A-M Montgomery, D W McCulloch, U Chakravarthy.   

Abstract

AIM: To study the relation between visual impairment and ability to care for oneself or a dependant in older people with age related macular degeneration (AMD).
METHOD: Cross sectional study of older people with visual impairment due to AMD in a specialised retinal service clinic. 199 subjects who underwent visual function assessment (fully corrected distance and near acuity and contrast sensitivity in both eyes), followed by completion of a package of questionnaires dealing with general health status (SF36), visual functioning (Daily Living Tasks Dependent on Vision, DLTV) and ability to care for self or provide care to others. The outcome measure was self reported ability to care for self and others. Three levels of self reported ability to care were identified--inability to care for self (level 1), ability to care for self but not others (level 2), and ability to care for self and others (level 3).
RESULTS: People who reported good general health status and visual functioning (that is, had high scores on SF36 and DLTV) were more likely to state that they were able to care for self and others. Similarly people with good vision in the better seeing eye were more likely to report ability to care for self and others. People with a distance visual acuity (DVA) worse than 0.4 logMAR (Snellen 6/15) had less than 50% probability of assigning themselves to care level 3 and those with DVA worse than 1.0 logMAR (Snellen 6/60) had a probability of greater than 50% or for assigning themselves to care level 1. Regression analyses with level of care as the dependent variable and demographic factors, DLTV subscales, and SF36 dimensions as the explanatory variables confirmed that the DLTV subscale 1 was the most important variable in the transition from care level 3 to care level 2. The regression analyses also confirmed that the DLTV subscale 2 was the most important in the transition from care level 3 to care level 1.
CONCLUSIONS: Ability to care for self and dependants has a strong relation with self reported visual functioning and quality of life and is adversely influenced by visual impairment. The acuity at which the balance of probability shifts in the direction of diminished ability to care for self or others is lower than the level set by social care agencies for provision of support. These findings have implications for those involved with visual rehabilitation and for studies of the cost effectiveness of interventions in AMD.

Entities:  

Mesh:

Year:  2004        PMID: 15317701      PMCID: PMC1772333          DOI: 10.1136/bjo.2003.032383

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Visual factors and mobility in persons with age-related macular degeneration.

Authors:  T Kuyk; J L Elliott
Journal:  J Rehabil Res Dev       Date:  1999-10

2.  Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam eye study.

Authors:  Barbara E K Klein; Scot E Moss; Ronald Klein; Kristine E Lee; Karen J Cruickshanks
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

3.  Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?

Authors:  M E McClure; P M Hart; A J Jackson; M R Stevenson; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

4.  Eye disease in a geriatric nursing home population.

Authors:  W G Whitmore
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

5.  A vision specific functional index for use in patients with age related macular degeneration.

Authors:  P M Hart; U Chakravarthy; M R Stevenson; J Q Jamison
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

6.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

7.  Prospective study of the impact of fear of falling on activities of daily living, SF-36 scores, and nursing home admission.

Authors:  R G Cumming; G Salkeld; M Thomas; G Szonyi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-05       Impact factor: 6.053

8.  Quality of life of low-vision patients and the impact of low-vision services.

Authors:  I U Scott; W E Smiddy; J Schiffman; W J Feuer; C J Pappas
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

Review 9.  How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Authors:  C G Owen; A E Fletcher; M Donoghue; A R Rudnicka
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

10.  Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community.

Authors:  J R Evans; A E Fletcher; R P L Wormald; E Siu-Woon Ng; S Stirling; L Smeeth; E Breeze; C J Bulpitt; M Nunes; D Jones; A Tulloch
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

View more
  17 in total

1.  Impact of age related macular degeneration on quality of life.

Authors:  J B Hassell; E L Lamoureux; J E Keeffe
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Further validation of the Daily Living Tasks Dependent on Vision: identification of domains.

Authors:  P M Hart; M R Stevenson; A-M Montgomery; K A Muldrew; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  [Quality of life by limited vision in old age: the example of age-related macula degeneration].

Authors:  H-W Wahl; V Heyl; N Langer
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

Review 4.  Applications of augmented reality in ophthalmology [Invited].

Authors:  Güneş Aydındoğan; Koray Kavaklı; Afsun Şahin; Pablo Artal; Hakan Ürey
Journal:  Biomed Opt Express       Date:  2020-12-21       Impact factor: 3.732

5.  Visual search with image modification in age-related macular degeneration.

Authors:  Emily Wiecek; Mary Lou Jackson; Steven C Dakin; Peter Bex
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-25       Impact factor: 4.799

6.  Mild Visual Impairment and Its Impact on Self-Care Among Older Adults.

Authors:  Rachel O'Conor; Samuel G Smith; Laura M Curtis; Julia Yoshino Benavente; Daniel P Vicencio; Michael S Wolf
Journal:  J Aging Health       Date:  2016-11-10

7.  Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.

Authors:  Robert P Finger; Monika Fleckenstein; Frank G Holz; Hendrik P N Scholl
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

8.  Help needed in medication self-management for people with visual impairment: case-control study.

Authors:  Roseleen M McCann; A Jonathan Jackson; Michael Stevenson; Martin Dempster; James C McElnay; Margaret E Cupples
Journal:  Br J Gen Pract       Date:  2012-08       Impact factor: 5.386

9.  Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis).

Authors:  Joshua D Stein; Paula Anne Newman-Casey; Tavag Mrinalini; Paul P Lee; David W Hutton
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

10.  Family caregiver social problem-solving abilities and adjustment to caring for a relative with vision loss.

Authors:  Jennifer K Bambara; Cynthia Owsley; Virginia Wadley; Roy Martin; Chebon Porter; Laura E Dreer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.